Abstract

Increasing evidence in recent years indicates that protein misfolding and aggregation, leading to ER stress, are central factors of pathogenicity in neurodegenerative diseases. This is particularly true in Huntington's disease (HD), where in contrast with other disorders, the cause is monogenic. Mutant huntingtin interferes with many cellular processes, but the fact that modulation of ER stress and of the unfolded response pathways reduces the toxicity, places these mechanisms at the core and gives hope for potential therapeutic approaches. There is currently no effective treatment for HD and it has a fatal outcome a few years after the start of symptoms of cognitive and motor impairment. Here we will discuss recent findings that shed light on the mechanisms of protein misfolding and aggregation that give origin to ER stress in neurodegenerative diseases, focusing on Huntington's disease, on the cellular response and on how to use this knowledge for possible therapeutic strategies.

Highlights

  • Reviewed by: Ehud Cohen, Hebrew University of Jerusalem, Israel Martin Lothar Duennwald, University of Western Ontario, Canada

  • PKR-like ER-localized eukaryotic initiation factor 2α (eIF2α) kinase (PERK) modulation has only been reported in Huntington’s disease (HD) cellular models (Leitman et al, 2014), but our own unpublished studies in mouse HD models, using a PERK activator that we have developed, showed significant protection

  • Our own unpublished results in HD cellular models suggest that the effect of pridopidine through Sigma-1 receptor (S1R) activation is by modulation of ER stress, affecting especially the PERK pathway

Read more

Summary

Introduction

Reviewed by: Ehud Cohen, Hebrew University of Jerusalem, Israel Martin Lothar Duennwald, University of Western Ontario, Canada. Increasing evidence in recent years indicates that protein misfolding and aggregation, leading to ER stress, are central factors of pathogenicity in neurodegenerative diseases.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call